Cargando…

Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome

Detalles Bibliográficos
Autores principales:	Matucci‐Cerinic, Caterina, Viglizzo, Gianmaria, Pastorino, Carlotta, Corcione, Anna, Prigione, Ignazia, Bocca, Paola, Bustaffa, Marta, Cecconi, Massimiliano, Gattorno, Marco, Volpi, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321118/ https://www.ncbi.nlm.nih.gov/pubmed/35470938 http://dx.doi.org/10.1111/pai.13770

Ejemplares similares

An Update on Familial Mediterranean Fever
por: Lancieri, Maddalena, et al.
Publicado: (2023)

Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab
por: Nihal, Aman, et al.
Publicado: (2022)

Hyper IgE in Childhood Eczema and Risk of Asthma in Chinese Children
por: Ng, Chantel, et al.
Publicado: (2016)

Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
por: Johar, Reshale A, et al.
Publicado: (2023)

Hyper IgE syndrome‐related disease treated with dupilumab: A case report
por: Kao, Andrew S., et al.
Publicado: (2023)

Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores
por: Herzum, Astrid, et al.
Publicado: (2023)

Case Report: Dupilumab Successfully Controls Severe Eczema in a Child With Elevated IgE Levels and Recurrent Skin Infections
por: Joshi, Tejas P., et al.
Publicado: (2021)

Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment
por: Bertoni, Arinna, et al.
Publicado: (2022)

Hyper IgE syndrome
por: Dang, Yun, et al.
Publicado: (2014)

Treatment of Pediatric Anogenital Warts in the Era of HPV-Vaccine: A Literature Review
por: Herzum, Astrid, et al.
Publicado: (2023)

A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis
por: Morandi, Fabio, et al.
Publicado: (2010)

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study
por: Oosterhaven, Jart A.F., et al.
Publicado: (2019)

Three cases of non‐atopic hyperkeratotic hand eczema treated with dupilumab
por: Loman, Laura, et al.
Publicado: (2020)

STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions
por: Tsilifis, Christo, et al.
Publicado: (2021)

An update on the hyper-IgE syndromes
por: Yong, Patrick FK, et al.
Publicado: (2012)

Spontaneous Gastrointestinal Perforations in STAT3-Deficient Hyper-IgE Syndrome
por: Bhattacharya, Sumona, et al.
Publicado: (2020)

HYPER IgE SYNDROME WITH UMBILICAL HERNIA
por: Hiremath, N C, et al.
Publicado: (2009)

Clinical Manifestations of Hyper IgE Syndromes
por: Freeman, Alexandra F., et al.
Publicado: (2010)

Autosomal-Recessive Hyper-IgE Syndrome
por: Liza, Mohapatra, et al.
Publicado: (2018)

Pediatric anaphylaxis and hyper IgE syndrome
por: Dosanjh, Amrita
Publicado: (2017)

Staphylococcus aureus and Hyper-IgE Syndrome
por: Park, Bonggoo, et al.
Publicado: (2020)

Hyper-IgE and Carcinoma in CADINS Disease
por: Pietzsch, Leonora, et al.
Publicado: (2022)

Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome
por: Mahdaviani, Seyed Alireza, et al.
Publicado: (2023)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
por: Peterson, Danielle M., et al.
Publicado: (2021)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022)

Relevance of Eosinophilia and Hyper-IgE in Immigrant Children
por: Belhassen-García, Moncef, et al.
Publicado: (2014)

Hyper IgE Syndrome and Renal Cell Carcinoma
por: Patel, Neel H., et al.
Publicado: (2017)

Clinical Profile of Hyper-IgE Syndrome in India
por: Saikia, Biman, et al.
Publicado: (2021)

Hyper IgE Syndrome in an Isolated Population in Israel
por: Lachover-Roth, Idit, et al.
Publicado: (2022)

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019)

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
por: Ma, Cindy S., et al.
Publicado: (2008)

Hyper-IgE Syndrome with STAT3 Mutation: A Case Report in Mainland China
por: Xie, Lixin, et al.
Publicado: (2010)

A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
por: Chaimowitz, Natalia S., et al.
Publicado: (2019)

Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients
por: Schwierzeck, Vera, et al.
Publicado: (2022)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Paediatric Spitzoid Neoplasms: 10-Year Retrospective Study Characterizing Histological, Clinical, Dermoscopic Presentation and FISH Test Results
por: Herzum, Astrid, et al.
Publicado: (2023)

Brain Abscess and Keratoacanthoma Suggestive of Hyper IgE Syndrome
por: Alyasin, Soheyla, et al.
Publicado: (2015)

Liver abscess in a boy with hyper IgE syndrome
por: Nandy, Sneha, et al.
Publicado: (2016)

STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome
por: Goel, Shubham, et al.
Publicado: (2018)

Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports
por: Deng, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rvmtlv7a14634fdar3s1j6b4ne